Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Infusion Therapy Devices Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The market for infusion therapy devices has experienced rapid expansion in recent years. This sector is forecast to grow from $13.33 billion in 2025 to $14.74 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.5%. The historical increase in this market can be attributed to several factors, including the rising incidence of chronic diseases, an increase in hospital admissions that require infusion therapy, the wider availability of oncology and diabetes treatments, the growing adoption of intravenous drug delivery, and improved accessibility to infusion devices.
The infusion therapy devices market size is poised for substantial expansion in the coming years. By 2030, this market is projected to reach $21.82 billion, demonstrating a compound annual growth rate (CAGR) of 10.3%. This anticipated growth during the forecast period is driven by several factors, including the escalating demand for home healthcare services, the increasing adoption of connected medical devices, the broader application of personalized medicine delivery, an intensified effort to minimize medication errors, and greater capital expenditure in smart hospital infrastructure. Key developments expected in the forecast period encompass a surge in the embrace of smart infusion pumps, a heightened need for portable and ambulatory infusion devices, the expanding integration of dose error reduction systems, a proliferation of home-based infusion therapy, and a reinforced emphasis on patient safety and monitoring.
Get A Free Sample Report With In-Depth Market Insights:
Infusion Therapy Devices Market Growth Catalysts And Demand Drivers
The escalating incidence of chronic diseases is anticipated to drive the expansion of the infusion therapy devices market in the foreseeable future. Chronic diseases are defined as long-term health conditions that persist for a year or more, necessitating continuous medical attention or limiting daily activities. The growing prevalence of these conditions can be attributed to poor lifestyle choices, sedentary habits, unhealthy diets, and environmental factors, alongside an increase in risk factors such as obesity, smoking, and stress. Infusion therapy devices facilitate the management of chronic diseases by enabling the precise and controlled delivery of medications and fluids directly into the bloodstream, thereby ensuring consistent and effective treatment for conditions like diabetes, autoimmune disorders, and cancer. This process improves patient outcomes, enhances convenience, and lessens the need for frequent hospital visits. For example, in January 2023, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, projected that by the year 2050, the number of individuals aged 50 years and above with at least one chronic illness will increase by 99.5%, rising from 71.522 million in 2020 to 142.66 million. Consequently, the increasing prevalence of chronic diseases is fueling the growth of the infusion therapy devices market.
Infusion Therapy Devices Market Segment Analysis Spotlighting Growth Areas
The infusion therapy devices market covered in this report is segmented –
1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors
2) By Mobility: Portable Infusion Pumps, Stationary Pumps
3) By Application: Oncology, Diabetes, Pain Management, Other Applications
4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users
Subsegments:
1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps
2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters
3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas
4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors
Infusion Therapy Devices Market Trends Shaping Long-Term Demand
Leading companies in the infusion therapy devices market are concentrating on developing innovative solutions, such as pressure-enabled drug delivery (PEDD) technology, to improve the treatment of liver and pancreatic tumors. Pressure-enabled drug delivery (PEDD) describes a drug delivery technique that employs pressure to enhance the infusion of therapeutic agents into tissues or organs, particularly in areas where conventional methods present challenges. For instance, in November 2024, TriSalus Life Sciences, a US-based medical technology company, launched the TriNav LV Infusion System and TriGuide Guiding Catheters. This expanded its pressure-enabled drug delivery (PEDD) portfolio, aiming to optimize therapeutic delivery, thus broadening treatment options and potentially improving outcomes for patients. The TriNav LV Infusion System incorporates unique features such as its suitability for larger blood vessels (3.5 to 5.0 mm), thereby extending the application of TriSalus’ Pressure-Enabled Drug Delivery (PEDD) technology to a broader patient population. This launch expands PEDD device compatibility from 1.5 mm to 5.0 mm vessels, offering interventional radiologists more treatment alternatives. TriGuide Guiding Catheters are characterized by a larger inner diameter, a lubricious lining, and a reverse curve design, which facilitates easier femoral access and enhances procedural efficiency. Early users have reported a 97% satisfaction rate, highlighting the system’s effectiveness and ease of use in oncology treatments.
Infusion Therapy Devices Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., Smiths Medical, Teleflex Incorporated
View The Full Infusion Therapy Devices Market Report:
Infusion Therapy Devices Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the infusion therapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model